Fetal bovine serum

Cosmetic Serum Market size to grow by USD 1.39 billion from 2022 to 2027; The rising demand for male beauty products to boost the market - Technavio

Retrieved on: 
Tuesday, January 16, 2024
Online, Woman, Supermarket, Natural product, Social media, Traction, Male, SPF, Fetal bovine serum, Organizing, Nicotinamide, Risk, Growth, Dermatology, Cosmetics, Skin, BPC, Retinol, USD, Pharmacy, FBS, Transport, Hyaluronic acid

NEW YORK, Jan. 16, 2024 /PRNewswire/ -- The cosmetic serum market is estimated to grow by USD 1.39 billion from 2023 to 2027, according to Technavio.

Key Points: 
  • NEW YORK, Jan. 16, 2024 /PRNewswire/ -- The cosmetic serum market is estimated to grow by USD 1.39 billion from 2023 to 2027, according to Technavio.
  • The report provides actionable insights and estimates the contribution of all regions to the growth of the global cosmetic serum market.
  • The Fetal Bovine Serum (FBS) Market size is estimated to grow by USD 294.16 million at a CAGR of 5.25% between 2023 and 2028.
  • The facial serum market size is estimated to grow at a CAGR of 7.92% between 2022 and 2027.

OMEAT COMPLETES CONSTRUCTION OF PILOT PLANT IN ITS STEADY MARCH TO SCALE UP

Retrieved on: 
Wednesday, November 8, 2023
Taste, Fetal bovine serum, Safety, Plasma, Collection, Meat, FBS, Fine chemical

LOS ANGELES, Nov. 8, 2023 /PRNewswire/ -- Omeat, the innovative cultivated meat company that launched out of stealth earlier this year, has successfully reached a significant milestone with the completion of its state-of-the-art pilot plant. This development marks a crucial step towards a sustainable and ethical future for meat production as the company scales towards commercialization. 

Key Points: 
  • The 15,000-square-foot pilot plant, located outside of Los Angeles, California, is designed to house bioreactors up to 10,000L in size and has the capacity to produce up to 400 tons of product annually.
  • The opening of Omeat's pilot plant is a significant step forward in bringing cultivated meat to consumers and addressing the growing demand for more sustainable protein sources.
  • In addition, the completion of the pilot plant will enable Omeat to demonstrate the intricacies of its process at scale, establishing a clear path for regulatory review and approval.
  • We remain confident that at scale, Omeat's prices will be less than conventional meat, providing accessibility to high-quality protein worldwide.

OMEAT APPOINTS PAVLE STOJKOVIC AS CHIEF STRATEGY OFFICER TO DRIVE THE COMPANY TOWARD COMMERCIALIZATION

Retrieved on: 
Thursday, September 14, 2023
Fetal bovine serum, Food, Sword Health, CSO, Marriage, Strategic planning, Parity, FBS, Protein, The New York Times, Ethics, Growth, Health, CPO, Sales, Management, Polaris

LOS ANGELES , Sept. 14, 2023 /PRNewswire/ -- Omeat, the innovative cultivated meat company that recently launched out of stealth, today announced the appointment of Pavle Stojkovic as Chief Strategy Officer (CSO). Previously serving as the company's Chief People Officer (CPO), Stojkovic brings diverse experience in the health and alternative protein space, arming him with the tools to implement systems and build internal infrastructures that will allow Omeat to scale rapidly. Before joining Omeat, Stojkovic was at Sword Health and The Athletic (acquired by The New York Times). He currently serves as an advisor to Climax Foods and Vegan-Friendly and invests in innovative food companies via Sustainable Food Ventures. Stojkovic's professional and personal commitment to a more sustainable future through food enables him to help Omeat transform the cultivated meat industry and the future of food.

Key Points: 
  • LOS ANGELES , Sept. 14, 2023 /PRNewswire/ -- Omeat , the innovative cultivated meat company that recently launched out of stealth, today announced the appointment of Pavle Stojkovic as Chief Strategy Officer (CSO).
  • Before joining Omeat, Stojkovic was at Sword Health and The Athletic (acquired by The New York Times).
  • He currently serves as an advisor to Climax Foods and Vegan-Friendly and invests in innovative food companies via Sustainable Food Ventures.
  • Stojkovic's appointment comes as part of Omeat's commitment to fortify its leadership team and drive innovation and growth in the market.

OMEAT IS AMONG THE FIRST REVENUE-GENERATING CULTIVATED MEAT COMPANIES WITH B2B LAUNCH OF PLENTY, A HUMANE & AFFORDABLE ALTERNATIVE TO FETAL BOVINE SERUM

Retrieved on: 
Monday, August 21, 2023
Harvard-MIT Data Center, Fetal bovine serum, Parity, Cell, Stem cell, Microsoft Exchange Server, Regenerative medicine, FBS, Animal, Collection, Ethics, LOS, Cytokine, Synthetic, Animal husbandry, Vaccine

LOS ANGELES, Aug. 21, 2023 /PRNewswire/ -- Omeat, the innovative cultivated meat company that recently launched out of stealth, unveiling its revolutionary and slaughter-free process, is now among the first revenue-generating cultivated meat companies. The company has launched and already had its first commercial sales of Plenty, an ethical replacement for Fetal Bovine Serum (FBS) that is equally effective but available for a fraction of the cost.

Key Points: 
  • FBS has long been used as a critical agent in the cell-culture process and was instrumental in early pioneering techniques for growing cultivated meat.
  • FBS is harvested from bovine fetuses that are taken from pregnant cows during their mutual slaughter.
  • These ethical and cost concerns have prompted companies, including those in the cultivated meat industry, to seek alternatives.
  • The market for Plenty includes any company focused on cultivated meat, regenerative medicine, vaccine production, or that otherwise employs cell-culture technology.

Insights on the Fetal Bovine Serum Global Market to 2028 - The Cell Culture Maintenance Sub-Segment Dominated the Market - ResearchAndMarkets.com

Retrieved on: 
Monday, October 17, 2022
Other Natural Resources, Natural Resources, Adoption, News, Fetal bovine serum, Government, Membrane, Growth, B cell, Organic acid, CAGR, Lipid, Research, Cell, MEA, Fibrin, Serum, Drug discovery, Sugar, ASEAN, FBS, Hormone, Maintenance, CRO, Vaccine, Fine chemical, Marketing

The global market for fetal bovine serum is projected to have a considerable CAGR during the forecast period.

Key Points: 
  • The global market for fetal bovine serum is projected to have a considerable CAGR during the forecast period.
  • The market growth is driven by extensive demand for fetal bovine serum in drug discovery and R&D, from basic research to specialty assays.
  • There are a variety of fetal bovine serum grades including standard and specialty grades available in the market based on application.
  • The Cell Culture Maintenance Sub-Segment dominated the Fetal Bovine Serum Market.

Global Fetal Bovine Serum Market Report 2022: Market to Surpass $1.25+ Billion in 2026 - Increase in R&D Towards Development of Novel Biopharmaceuticals - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 22, 2022
Health, Biotechnology, Biotechnology, CAGR, Fertilisation, GE Healthcare, Fetal bovine serum, Drug development, Animal, Carbon, Demography, FBS, Thermo Fisher Scientific, Research, Human, Steroid, Sartorius AG, Growth, Bio-Techne, Drug discovery, Fibrin, Merck Group, Charcoal, Partnership, Exosome, Application, Serum, Hormone, Organization, Vaccine, Fine chemical

The "Fetal Bovine Serum Global Market Report 2022: By Product, By Application, By End-User" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Fetal Bovine Serum Global Market Report 2022: By Product, By Application, By End-User" report has been added to ResearchAndMarkets.com's offering.
  • The fetal bovine serum market consists of sales of fetal bovine serum by entities (organizations, sole traders, and partnerships) that are engaged in manufacturing fetal bovine serum and related services.
  • The main types of fetal bovine serum are charcoal stripped, chromatographic, dialyzed fetal bovine serum, exosome depleted, stem cell, others.
  • Global Fetal Bovine Serum Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Worldwide Fetal Bovine Serum Industry to 2026 - by Product Type, End-user, Application and Region - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 1, 2021
Biotechnology, Pharmaceutical, Health, Blood, Fetal bovine serum, Serum

Similarly, by application, the fetal bovine serum market is categorized into industrial research and scientific research.

Key Points: 
  • Similarly, by application, the fetal bovine serum market is categorized into industrial research and scientific research.
  • Geographically, North America dominated the fetal bovine serum market in 2020, and is expected to grow continuously during the forecast period.
  • The factors that drive the growth of the fetal bovine serum market in the region include the growing awareness about fetal bovine serums among the population and rising funding for R&D activities.
  • North America is the largest market for manufacturing bio-pharmaceutical and laboratory products, hence create enormous opportunities for the fetal bovine serum market that drives the market in the region.

Global Cultured Meat Market Insights, Covid-19 Impact, Competition and Forecast 2021-2030: Focus on Canada, Germany, Japan, Singapore, UK, & US - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 18, 2021
Food, Beverage, Retail, Articles, Food and drink, Branches of biology, Biotechnology, Meat, Sustainable food system, Blood, Cultured meat, Fetal bovine serum, Stem cell, Veganism, Serum

Further, the growing awareness about the lab grown meat and other health related benefits are going to lead the market in the forecast period.\nAlso, the growing demand of meat and increasing slaughter of animals is forcing to move towards the consumption of cultured meat.

Key Points: 
  • Further, the growing awareness about the lab grown meat and other health related benefits are going to lead the market in the forecast period.\nAlso, the growing demand of meat and increasing slaughter of animals is forcing to move towards the consumption of cultured meat.
  • Rising technological advancements and investment in new startups involved in this industry are expected to boost the market growth in the forecast period.\nFurthermore, the growing adoption of veganism and healthy lifestyle is directly influencing the growth.
  • This trend is observed in numerous parts of the North American and Asia Pacific regions.\nElsewhere in Europe, the UK\'s \'Higher Steaks\' is growing stem cells for the production of mince for pork sausages.
  • Instead of using fetal bovine serum, the company uses protocols exclusively licensed to it by its collaborators, the University of Minnesota, that allow it to reprogram stem cells into muscle and fat tissues.\n'

North America Cell Line Development Serum Market Forecast to 2027 - COVID-19 Impact and Regional Analysis - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 18, 2021
Biotechnology, Science, Health, Other Science, Blood, Branches of biology, Biology, Fetal bovine serum, Serum, Life sciences

The "North America Cell Line Development Serum Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Type; By Application; and Country" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "North America Cell Line Development Serum Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Type; By Application; and Country" report has been added to ResearchAndMarkets.com's offering.
  • The North America cell line development serum market is expected to reach US$ 502.91 million in 2027 from US$ 307.29 million in 2019.
  • Based on type, the North America cell line development serum market is segmented into fetal bovine serum, porcine serum, adult bovine serum, horse serum, and other animal serum.
  • Based on application, the North America cell line development serum market is segmented into tissue engineering and regenerative medicines, academic research, drug discovery, toxicity testing, and bioproduction.

Global Cell Line Development Serum Market to 2027: Drug Development and Adoption of Novel Technologies for Cell Line Development Gaining Momentum

Retrieved on: 
Friday, January 29, 2021
Blood, Branches of biology, Fetal bovine serum, Serum, Biology

DUBLIN, Jan. 29, 2021 /PRNewswire/ -- The "Cell Line Development Serum Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type; By Application; and Geography" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Jan. 29, 2021 /PRNewswire/ -- The "Cell Line Development Serum Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type; By Application; and Geography" report has been added to ResearchAndMarkets.com's offering.
  • The report provides trends prevailing in the global cell line development serum market, and the drivers and hindrances pertaining to the market growth.
  • Based on type, the global cell line development serum market is segmented into fetal bovine serum, adult bovine serum, porcine serum, horse serum, other animal serum.
  • Increasing adoption of regenerative medicines and rising R& D investments and collaborations among by pharmaceutical and biotechnology companies treatments are the key factors driving the growth of the cell line development serum market.